Autologous platelet-rich plasma (PRP) infusions and biomarkers of ovarian and endometrial rejuvenation and aging mitigation
Aaron Traywick and E Scott Sills
Inovium Rejuvenation, USA
Center for Advanced Genetics, USA
: Androl Gynecol: Curr Res
Abstract
The purpose of two separate clinical trials was to study and evaluate the beneficial effects of infusions of autologous platelet-rich plasma on fertility, the aging process, and general and reproductive health using blood and hormone biomarkers in peri-menopausal and menopausal women seeking fertility. Data generated as a result of the trial will be used to support additional organ-specific and disease-specific PRP-based treatments, particularly in brain and musculoskeletal tissue and stem cell rejuvenation treatments in women, as part of an ongoing research collaborative with researchers at UC-Berkeley. The most prominent data as generated from nearly 100 women participating in the 2017 trials will be presented.
Biography
Aaron Tray wick serves as the Managing Director of the Inovium Ovarian Rejuvenation Trial, working with a team of professional researchers, clinicians and organizers around the world to explore new, safe and affordable innovations in the fertility sciences and patient access to lifesaving treatments in terminal conditions and health span. He is a Community Organizer, Public Policy Professional and Human Rights Advocate who has worked in the public health, healthcare technology and healthcare access communities for the past five years. He has served in various public policy leadership and service capacities in positions ranging from local and state government to members of the United States Congress
E-mail: e: aaron@ascendancebiomed.com
